• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受高剂量左甲状腺素治疗的儿童及青少年女性的骨矿物质密度

Bone mineral density in children and adolescent females treated with high doses of L-thyroxine.

作者信息

Radetti G, Castellan C, Tatò L, Platter K, Gentili L, Adami S

机构信息

Department of Pediatrics, General Hospital of Bolzano, Italy.

出版信息

Horm Res. 1993;39(3-4):127-31. doi: 10.1159/000182712.

DOI:10.1159/000182712
PMID:8262473
Abstract

Single-photon absorptiometry was used to assess forearm bone mineral content (BMC) at a proximal site (PBMC) and at a more distal site (DBMC) of the non-dominant distal forearm in 20 children and adolescent females taking high doses of L-thyroxine (120 micrograms/m2/day) for a period of 6-96 months for endemic goiter, Hashimoto's thyroiditis or thyroid cancer. PBMC was significantly reduced compared to controls (p < 0.002). No correlation was found between PBMC, the values of circulating thyroid hormones and the indices of tissue hyperthyroidism such as TSH and systolic time intervals (STI), suggesting that bone is a very sensitive target for thyroid hormones. Further studies are necessary to confirm our findings and to verify their clinical significance. At present, we believe that suppressive doses of L-thyroxine should be reserved for cancer patients only.

摘要

采用单光子吸收法,对20名因地方性甲状腺肿、桥本甲状腺炎或甲状腺癌而长期(6 - 96个月)服用高剂量L-甲状腺素(120微克/平方米/天)的儿童及青春期女性非优势侧前臂近端(近端骨矿物质含量,PBMC)和更远端部位(远端骨矿物质含量,DBMC)的前臂骨矿物质含量(BMC)进行评估。与对照组相比,PBMC显著降低(p < 0.002)。未发现PBMC、循环甲状腺激素值与组织甲状腺功能亢进指标(如促甲状腺激素和收缩期时间间期,STI)之间存在相关性,这表明骨骼是甲状腺激素非常敏感的靶点。需要进一步研究以证实我们的发现并验证其临床意义。目前,我们认为仅应将抑制剂量的L-甲状腺素用于癌症患者。

相似文献

1
Bone mineral density in children and adolescent females treated with high doses of L-thyroxine.接受高剂量左甲状腺素治疗的儿童及青少年女性的骨矿物质密度
Horm Res. 1993;39(3-4):127-31. doi: 10.1159/000182712.
2
Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.甲状腺癌和慢性淋巴细胞性甲状腺炎绝经后女性长期接受左甲状腺素治疗后的脊柱骨量
Calcif Tissue Int. 1994 Jan;54(1):16-9. doi: 10.1007/BF00316283.
3
Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis.左甲状腺素给药对桥本甲状腺炎患者抗甲状腺抗体水平、血脂谱及甲状腺体积的影响。
Thyroid. 1996 Jun;6(3):183-8. doi: 10.1089/thy.1996.6.183.
4
Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.通过定量计算机断层扫描和单光子吸收法测定亚临床甲状腺功能亢进症患者的骨密度:绝经后女性早期骨质疏松的风险
Clin Endocrinol (Oxf). 1992 May;36(5):511-7. doi: 10.1111/j.1365-2265.1992.tb02254.x.
5
Cardiovascular effects of long-term L-thyroxine therapy for Hashimoto's thyroiditis in children and adolescents.长期左甲状腺素治疗对儿童及青少年桥本甲状腺炎的心血管影响。
Eur J Endocrinol. 1995 Jun;132(6):688-92. doi: 10.1530/eje.0.1320688.
6
Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone.甲状腺激素治疗的甲状腺功能正常的甲状腺肿女性前臂骨矿物质含量降低及骨转换增加的生化证据。
Clin Endocrinol (Oxf). 1990 Jul;33(1):107-17. doi: 10.1111/j.1365-2265.1990.tb00471.x.
7
Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.接受左甲状腺素替代治疗的绝经前女性的骨矿物质密度和代谢
Clin Endocrinol (Oxf). 1994 Dec;41(6):747-55. doi: 10.1111/j.1365-2265.1994.tb02789.x.
8
Bone mineral density and metabolism in children treated with L-thyroxine.
J Pediatr Endocrinol Metab. 1999 Jul-Aug;12(4):519-23. doi: 10.1515/jpem.1999.12.4.519.
9
Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.接受抑制剂量甲状腺素治疗甲状腺癌患者的骨矿物质密度
N Z Med J. 1993 Oct 27;106(966):443-4.
10
Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.接受超生理剂量甲状腺素治疗的甲状腺癌患者的骨密度变化和骨转换
Eur J Med Res. 2005 Nov 16;10(11):480-8.

引用本文的文献

1
Association between serum TSH concentration and bone mineral density: an umbrella review.血清促甲状腺激素浓度与骨密度之间的关联:一项伞状综述。
Hormones (Athens). 2024 Sep;23(3):547-565. doi: 10.1007/s42000-024-00555-w. Epub 2024 Apr 6.
2
Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients.年轻成年分化型甲状腺癌患者长期抑制性左甲状腺素治疗后的骨矿物质密度和骨微结构
J Bone Miner Metab. 2016 Jul;34(4):417-21. doi: 10.1007/s00774-015-0680-4. Epub 2015 Jun 9.
3
Osteoporosis in children and adolescents: etiology and management.
儿童和青少年骨质疏松症:病因与管理
Paediatr Drugs. 2005;7(5):295-323. doi: 10.2165/00148581-200507050-00003.
4
[Thyroid disease in pregnancy].[妊娠期甲状腺疾病]
Aten Primaria. 2001 Feb 28;27(3):190-6. doi: 10.1016/s0212-6567(01)78796-3.
5
Alkaline phosphatase bone isoenzyme and osteocalcin in the serum of hyperthyroid cats.甲状腺功能亢进猫血清中的碱性磷酸酶骨同工酶和骨钙素
Can Vet J. 1996 Dec;37(12):735-9.
6
Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study.接受左甲状腺素治疗的青春期女性的骨矿物质密度:一项纵向研究。
Eur J Pediatr. 1996 Jun;155(6):452-7. doi: 10.1007/BF01955180.
7
A longitudinal assessment of bone loss in women with levothyroxine-suppressed benign thyroid disease and thyroid cancer.左甲状腺素抑制治疗的良性甲状腺疾病和甲状腺癌女性患者骨丢失的纵向评估。
Calcif Tissue Int. 1995 Jun;56(6):521-5. doi: 10.1007/BF00298581.